Cure for Chemobrain, a relief for Cancer patients
Published: June 8, 2005
Researchers at the University of Cincinnati have developed a new treatment which can help Cancer patients suffering with the problem of Chemobrain ; a common consequence of chemotherapy that causes memory problems,confusion and difficulty in concentrating.
“The study showed that up to 50 mg a day of d-MPH (dexmethyphenidate) drug is safe and effective for relieving chemobrain in adult cancer patients and it should be considered as a treatment,” said Dr. Elyse Lower, the leading researcher of the University of Cincinnati’s (UC) and a professor of hematology/oncology.
According to an estimate chemobrain occurs in as many as 99 per cent of breast and ovarian cancer patients receiving chemotherapy or radiation treatments. Sixty-one percent of these patients continue to experience fatigue and memory problems long after their cancer treatment has stopped.
Symptoms of chemobrain can also include lack of focus, inability to organize daily activities, mental confusion, memory loss and decreased mental clarity.
The 154 cancer survivors at 21 medical centers showed significant reduction in fatigue and improvement in memory when treated with dosages of 10 mg to 50 mg of d-MPH per day,when compared with a control group receiving a placebo, informed Dr. Lower.
All the patients, who had a median age of 53 years, had completed at least four cycles of chemotherapy at least two months before the study began. Ninety percent of them were female (76 percent with breast cancer and 14 per cent with ovarian cancer), 79 per cent were white and 9 percent were African-American.
If you enjoyed this good news Subscribe to Good News Blog
Share this
To share this simply copy and paste one of the below URL's: